CD55 and metabolic dysfunction-associated steatohepatitis: Hepatic DAF mRNA and protein levels showed a trend to be increased in patients with NASH compared to controls (mRNA: 2.37±0.72 vs. 1.00±0.14; p = 0.22, figure 3D/Protein: 1.97±0.67 vs. 1.00±0.21; p = 0.28, figure 3E).